Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

2.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.2K
Pulmonary Function Tests01:25

Pulmonary Function Tests

1.0K
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
1.0K
Standard Precaution01:26

Standard Precaution

3.5K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
3.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

888
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
888
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

4.9K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.9K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

5.1K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood Eosinophil Counts in Healthy Volunteers and in Patients with Asthma and COPD in India: A Multi-Centre Cross-Sectional Report.

International journal of chronic obstructive pulmonary disease·2025
Same author

Closing gaps in asthma care in India - World Asthma Day 2022.

The Indian journal of medical research·2022
Same author

Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group.

Lung India : official organ of Indian Chest Society·2022
Same author

Association between air pollution, body mass index, respiratory symptoms, and asthma among adolescent school children living in Delhi, India.

Lung India : official organ of Indian Chest Society·2021
Same author

Use of Thiols in the Treatment of COVID-19: Current Evidence.

Lung·2021
Same author

COPD Management during the COVID-19 pandemic.

Lung India : official organ of Indian Chest Society·2021

Related Experiment Video

Updated: Apr 7, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

7.9K

Infection control in the pulmonary function test laboratory.

Shweta Amol Rasam1, Komalkirti Keshavkiran Apte2, Sundeep Santosh Salvi3

  • 1Lung Function Testing Department, Chest Research Foundation, Pune, Maharashtra, India.

Lung India : Official Organ of Indian Chest Society
|July 17, 2015
PubMed
Summary

Pulmonary function test (PFT) laboratories can pose a risk of cross-infection, though rare. Implementing enhanced infection control measures, including disinfection and patient management, is crucial to minimize pathogen transmission.

Keywords:
Cross infection in a PFT labpotential pathogenspreventive and control strategies

More Related Videos

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology
11:13

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology

Published on: October 3, 2016

15.4K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.7K

Related Experiment Videos

Last Updated: Apr 7, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

7.9K
Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology
11:13

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology

Published on: October 3, 2016

15.4K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.7K

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Laboratory Science

Background:

  • Pulmonary function testing (PFT) is vital for diagnosing lung diseases.
  • Cross-infection in PFT laboratories, while uncommon, is a documented risk globally.
  • Infection control in PFT settings requires careful consideration of laboratory infrastructure, patient volume, and disinfection protocols.

Purpose of the Study:

  • To raise awareness of potential pathogens and transmission risks in PFT laboratories.
  • To suggest effective infection control measures for PFT laboratory environments.
  • To identify gaps in current PFT laboratory infection control practices, particularly in India.

Main Methods:

  • Review of existing literature on cross-infections in pulmonary function test laboratories.
  • Analysis of factors contributing to infection transmission, including infrastructure and patient flow.
  • Proposal of infection control strategies focusing on disinfection, sterilization, and patient segregation.

Main Results:

  • PFT laboratory design, patient throughput, and disinfection methods significantly influence infection transmission.
  • Simple and specialized measures can substantially reduce the risk of cross-infection.
  • Current infection control practices in Indian PFT labs show deficiencies, necessitating improvement.

Conclusions:

  • Effective infection control in PFT labs requires a multi-faceted approach addressing disinfection, sterilization, and patient management.
  • There is a need for user-friendly, cost-effective infection control solutions tailored for PFT laboratories in India.
  • Further research is essential to identify specific pathogens and evaluate existing strategies for robust cross-infection control recommendations.